BILIARY CANCER METASTATIC

BILIARY CANCER METASTATIC was reported 52 times

These drug classes are most commonly taken by patients reporting BILIARY CANCER METASTATIC:

# Drug Count
0 Platinum-based Drug [EPC] 5
1 Loop Diuretic [EPC] 4
2 Nucleoside Metabolic Inhibitor [EPC] 4
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 4
4 Tumor Necrosis Factor Blocker [EPC] 3
5 Vitamin C [EPC] 3
6 Angiotensin 2 Receptor Blocker [EPC] 2
7 Benzodiazepine [EPC] 2
8 Dihydropyridine Calcium Channel Blocker [EPC] 2
9 Factor Xa Inhibitor [EPC] 2
10 GLP-1 Receptor Agonist [EPC] 2
11 Interleukin-12 Antagonist [EPC] 2
12 Interleukin-23 Antagonist [EPC] 2
13 Opioid Agonist [EPC] 2
14 RANK Ligand Inhibitor [EPC] 2
15 5-alpha Reductase Inhibitor [EPC] 1
16 Aldosterone Antagonist [EPC] 1
17 Aromatase Inhibitor [EPC] 1
18 Atypical Antipsychotic [EPC] 1
19 CD20-directed Cytolytic Antibody [EPC] 1
20 CTLA-4-directed Blocking Antibody [EPC] 1
21 Calcium Channel Blocker [EPC] 1
22 Cannabinoid [EPC] 1
23 Corticosteroid [EPC] 1
24 Epidermal Growth Factor Receptor Antagonist [EPC] 1
25 Estrogen [EPC] 1
26 Expectorant [EPC] 1
27 GLP-2 Analog [EPC] 1
28 HER2/neu Receptor Antagonist [EPC] 1
29 HMG-CoA Reductase Inhibitor [EPC] 1
30 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
31 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
32 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
33 Insulin Analog [EPC] 1
34 Interleukin-1 Receptor Antagonist [EPC] 1
35 Interleukin-6 Receptor Antagonist [EPC] 1
36 Isocitrate Dehydrogenase 1 Inhibitor [EPC] 1
37 Muscle Relaxant [EPC] 1
38 Osmotic Laxative [EPC] 1
39 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
40 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
41 Programmed Death Ligand-1 Blocker [EPC] 1
42 Prostaglandin Analog [EPC] 1
43 Proton Pump Inhibitor [EPC] 1
44 Serotonin Reuptake Inhibitor [EPC] 1
45 Thiazide Diuretic [EPC] 1
46 Vitamin B12 [EPC] 1
47 Vitamin D [EPC] 1
48 beta-Adrenergic Blocker [EPC] 1